Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 103

1.

Disclosure of stuttering and quality of life in people who stutter.

Boyle MP, Milewski KM, Beita-Ell C.

J Fluency Disord. 2018 Dec;58:1-10. doi: 10.1016/j.jfludis.2018.10.003. Epub 2018 Oct 15.

PMID:
30352701
2.

Lumacaftor/Ivacaftor reduces pulmonary exacerbations in patients irrespective of initial changes in FEV1.

McColley SA, Konstan MW, Ramsey BW, Stuart Elborn J, Boyle MP, Wainwright CE, Waltz D, Vera-Llonch M, Marigowda G, Jiang JG, Rubin JL.

J Cyst Fibros. 2018 Aug 23. pii: S1569-1993(18)30719-7. doi: 10.1016/j.jcf.2018.07.011. [Epub ahead of print]

3.

Eradication of persistent methicillin-resistant Staphylococcus aureus infection in cystic fibrosis.

Dezube R, Jennings MT, Rykiel M, Diener-West M, Boyle MP, Chmiel JF, Dasenbrook EC.

J Cyst Fibros. 2018 Aug 18. pii: S1569-1993(18)30702-1. doi: 10.1016/j.jcf.2018.07.005. [Epub ahead of print]

PMID:
30131297
4.

Self-Esteem, Self-Efficacy, and Social Support as Predictors of Communicative Participation in Adults Who Stutter.

Boyle MP, Beita-Ell C, Milewski KM, Fearon AN.

J Speech Lang Hear Res. 2018 Aug 8;61(8):1893-1906. doi: 10.1044/2018_JSLHR-S-17-0443.

PMID:
29998290
5.

CFTR modulator theratyping: Current status, gaps and future directions.

Clancy JP, Cotton CU, Donaldson SH, Solomon GM, VanDevanter DR, Boyle MP, Gentzsch M, Nick JA, Illek B, Wallenburg JC, Sorscher EJ, Amaral MD, Beekman JM, Naren AP, Bridges RJ, Thomas PJ, Cutting G, Rowe S, Durmowicz AG, Mense M, Boeck KD, Skach W, Penland C, Joseloff E, Bihler H, Mahoney J, Borowitz D, Tuggle KL.

J Cyst Fibros. 2018 Jun 19. pii: S1569-1993(18)30585-X. doi: 10.1016/j.jcf.2018.05.004. [Epub ahead of print] Review.

6.

Enacted stigma and felt stigma experienced by adults who stutter.

Boyle MP.

J Commun Disord. 2018 May - Jun;73:50-61. doi: 10.1016/j.jcomdis.2018.03.004. Epub 2018 Mar 13.

PMID:
29574262
7.

Risk factors for persistent Aspergillus respiratory isolation in cystic fibrosis.

Hong G, Psoter KJ, Jennings MT, Merlo CA, Boyle MP, Hadjiliadis D, Kawut SM, Lechtzin N.

J Cyst Fibros. 2018 Sep;17(5):624-630. doi: 10.1016/j.jcf.2018.01.008. Epub 2018 Feb 12.

PMID:
29444760
8.

Frequency of small-colony variants and antimicrobial susceptibility of methicillin-resistant Staphylococcus aureus in cystic fibrosis patients.

Suwantarat N, Rubin M, Bryan L, Tekle T, Boyle MP, Carroll KC, Jennings MT.

Diagn Microbiol Infect Dis. 2018 Apr;90(4):296-299. doi: 10.1016/j.diagmicrobio.2017.11.012. Epub 2017 Dec 2.

PMID:
29343421
9.

C-reactive protein as a predictor of low trough infliximab concentrations in patients who lose response to infliximab.

Boyle MP, Moss AC, O'Toole AM, Vaughn B, Cheifetz AS.

J Dig Dis. 2017 Dec;18(12):678-683. doi: 10.1111/1751-2980.12560.

PMID:
29119722
10.

Self-stigma and its associations with stress, physical health, and health care satisfaction in adults who stutter.

Boyle MP, Fearon AN.

J Fluency Disord. 2018 Jun;56:112-121. doi: 10.1016/j.jfludis.2017.10.002. Epub 2017 Oct 24.

PMID:
29111141
11.

Airway Mucosal Host Defense Is Key to Genomic Regulation of Cystic Fibrosis Lung Disease Severity.

Polineni D, Dang H, Gallins PJ, Jones LC, Pace RG, Stonebraker JR, Commander LA, Krenicky JE, Zhou YH, Corvol H, Cutting GR, Drumm ML, Strug LJ, Boyle MP, Durie PR, Chmiel JF, Zou F, Wright FA, O'Neal WK, Knowles MR.

Am J Respir Crit Care Med. 2018 Jan 1;197(1):79-93. doi: 10.1164/rccm.201701-0134OC.

PMID:
28853905
12.

Personal Perceptions and Perceived Public Opinion About Stuttering in the United States: Implications for Anti-Stigma Campaigns.

Boyle MP.

Am J Speech Lang Pathol. 2017 Aug 15;26(3):921-938. doi: 10.1044/2017_AJSLP-16-0191.

PMID:
28785764
13.

Home Monitoring of Patients with Cystic Fibrosis to Identify and Treat Acute Pulmonary Exacerbations. eICE Study Results.

Lechtzin N, Mayer-Hamblett N, West NE, Allgood S, Wilhelm E, Khan U, Aitken ML, Ramsey BW, Boyle MP, Mogayzel PJ Jr, Gibson RL, Orenstein D, Milla C, Clancy JP, Antony V, Goss CH; eICE Study Team.

Am J Respir Crit Care Med. 2017 Nov 1;196(9):1144-1151. doi: 10.1164/rccm.201610-2172OC.

14.

Risk factors for persistent methicillin-resistant Staphylococcus aureus infection in cystic fibrosis.

Jennings MT, Dasenbrook EC, Lechtzin N, Boyle MP, Merlo CA.

J Cyst Fibros. 2017 Nov;16(6):681-686. doi: 10.1016/j.jcf.2017.04.010. Epub 2017 Apr 23.

PMID:
28446387
15.

Nanoparticles that do not adhere to mucus provide uniform and long-lasting drug delivery to airways following inhalation.

Schneider CS, Xu Q, Boylan NJ, Chisholm J, Tang BC, Schuster BS, Henning A, Ensign LM, Lee E, Adstamongkonkul P, Simons BW, Wang SS, Gong X, Yu T, Boyle MP, Suk JS, Hanes J.

Sci Adv. 2017 Apr 5;3(4):e1601556. doi: 10.1126/sciadv.1601556. eCollection 2017 Apr.

16.

Digitoxin for Airway Inflammation in Cystic Fibrosis: Preliminary Assessment of Safety, Pharmacokinetics, and Dose Finding.

Zeitlin PL, Diener-West M, Callahan KA, Lee S, Talbot CC Jr, Pollard B, Boyle MP, Lechtzin N.

Ann Am Thorac Soc. 2017 Feb;14(2):220-229. doi: 10.1513/AnnalsATS.201608-649OC.

17.

Lumacaftor/Ivacaftor Treatment of Patients with Cystic Fibrosis Heterozygous for F508del-CFTR.

Rowe SM, McColley SA, Rietschel E, Li X, Bell SC, Konstan MW, Marigowda G, Waltz D, Boyle MP; VX09-809-102 Study Group.

Ann Am Thorac Soc. 2017 Feb;14(2):213-219. doi: 10.1513/AnnalsATS.201609-689OC.

18.

A comparison of three strategies for reducing the public stigma associated with stuttering.

Boyle MP, Dioguardi L, Pate JE.

J Fluency Disord. 2016 Dec;50:44-58. doi: 10.1016/j.jfludis.2016.09.004. Epub 2016 Sep 30.

PMID:
27865229
19.

Microstructural alterations of sputum in cystic fibrosis lung disease.

Duncan GA, Jung J, Joseph A, Thaxton AL, West NE, Boyle MP, Hanes J, Suk JS.

JCI Insight. 2016 Nov 3;1(18):e88198.

20.

Efficacy and safety of lumacaftor/ivacaftor combination therapy in patients with cystic fibrosis homozygous for Phe508del CFTR by pulmonary function subgroup: a pooled analysis.

Elborn JS, Ramsey BW, Boyle MP, Konstan MW, Huang X, Marigowda G, Waltz D, Wainwright CE; VX-809 TRAFFIC and TRANSPORT study groups.

Lancet Respir Med. 2016 Aug;4(8):617-626. doi: 10.1016/S2213-2600(16)30121-7. Epub 2016 Jun 10.

PMID:
27298017

Supplemental Content

Loading ...
Support Center